| |
|
|
|
Intec Pharma Ltd.  
|
|
7.9652 -0.185 (-0.02%) |
01-17 10:46 |
|
Open: |
8.16 |
Pre close: |
8.15 |
Target:
|
10.26
|
|
High: |
8.16 |
Low: |
7.9 |
Resistance:
|
8.78
10.26
|
|
Volume: |
55,798 |
Market Cap: |
265M |
Support:
|
7.17
6.18
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.24
 |
MACD |
MACD(12,26):
|
0.38 |
|
MA(20): |
7.63  |
Signal(12,26,9): |
0.40 |
|
MA(100): |
5.86 |
Stochastic Oscillator |
%K(14,3):
|
74.46 |
|
MA(250): |
5.45 |
%D(3): |
78.61 |
|
Average Volume(K) |
3-Month: |
28189
|
52-Week |
High:
|
8.78 |
|
10-Days: |
16890 |
Low: |
3.55 |
|
RSI |
RSI(14):
|
56.20 |
Change(%): |
14.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-61.4 |
Shares Out. (M) |
33.23 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-57.4 |
Shares Float (M) |
33.23 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
44.90 |
|
Forward EPS |
-1.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.190 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.91 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-38.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-25.80 |
P/CF |
-6.97 |
|
|
|
|
|
|
